LTR Pharma's SPONTAN nasal spray development pathway has reached another major milestone as it works toward US market entry. ...

The Food and Drug Administration (FDA) has issued a Complete Response Letter to Milestone Pharmaceuticals regarding the New Drug Application (NDA) for ...

Milestone Pharmaceuticals said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of ...

Clearing clinical and regulatory hurdles in the development of a fast-acting nasal spray for a heart condition has been a ...

CRL focused on CMC; no clinical issues relating to etripamil raised$69.7M in cash, cash equivalents and short-term investments as of December 31, ...

Shares of ARS Pharmaceuticals bounded higher Thursday after the company reported an unexpected fourth-quarter metrics.

NEW YORK, NY / ACCESS Newswire / March 11, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Viatris Inc. ("Viatris Inc.") (NASDAQ:VTRS) concerning possible ...

In this article, we are going to take a look at where Viatris Inc. (NASDAQ:VTRS) stands against the other large-cap stocks. The big and large-cap stocks have spearheaded the rally in the past two ...

A NASAL spray containing an anti-CD3 monoclonal antibody has shown promising results in ameliorating traumatic brain injury (TBI) in a mouse model, reducing central nervous system damage and improving ...

A woman has told how she was left in hospital "unable to breathe" after suffering a severe reaction to an unlicensed nasal tanning spray she bought online. Edith Eagle said she felt like she was ...

Looking at the universe of stocks we cover at Dividend Channel, on 3/10/25, Evergy Inc (Symbol: EVRG), Viatris Inc (Symbol: VTRS), and Becton, Dickinson & Co (Symbol: BDX) will all trade ex ...

March 6, 2025 – The FDA has approved a new nose spray that can quickly treat severe ... Common side effects include nasal discomfort or tingling, nosebleeds, sneezing, runny or dry nose or ...